These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8968503)

  • 1. Role of multiple cAMP-specific phosphodiesterase variants.
    Bushnik T; Conti M
    Biochem Soc Trans; 1996 Nov; 24(4):1014-9. PubMed ID: 8968503
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclic nucleotides and phosphodiesterases in platelets.
    Haslam RJ; Dickinson NT; Jang EK
    Thromb Haemost; 1999 Aug; 82(2):412-23. PubMed ID: 10605732
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclic nucleotide phosphodiesterases: gene complexity, regulation by phosphorylation, and physiological implications.
    Burns F; Zhao AZ; Beavo JA
    Adv Pharmacol; 1996; 36():29-48. PubMed ID: 8783553
    [No Abstract]   [Full Text] [Related]  

  • 4. Phosphodiesterases: the journey towards therapeutics.
    Torphy TJ; Page C
    Trends Pharmacol Sci; 2000 May; 21(5):157-9. PubMed ID: 10885973
    [No Abstract]   [Full Text] [Related]  

  • 5. Participation of peripheral and spinal phosphodiesterases 4 and 5 in inflammatory pain.
    Torres-López JE; Argüelles CF; Granados-Soto V
    Proc West Pharmacol Soc; 2002; 45():141-3. PubMed ID: 12434560
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.
    Rybalkin SD; Bornfeldt KE
    Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733
    [No Abstract]   [Full Text] [Related]  

  • 7. A theoretical study of the effects of cyclic AMP phosphodiesterases during aggregation in Dictyostelium.
    Nanjundiah V; Malchow D
    J Cell Sci; 1976 Oct; 22(1):49-58. PubMed ID: 185228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplicity within cyclic nucleotide phosphodiesterases.
    Rybalkin SD; Beavo JA
    Biochem Soc Trans; 1996 Nov; 24(4):1005-9. PubMed ID: 8968501
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
    Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
    Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the study of Ca2+/CaM-activated phosphodiesterases: expression and physiological functions.
    Zhao AZ; Yan C; Sonnenburg WK; Beavo JA
    Adv Second Messenger Phosphoprotein Res; 1997; 31():237-51. PubMed ID: 9344255
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement of motility and acrosome reaction in human spermatozoa: differential activation by type-specific phosphodiesterase inhibitors.
    Fisch JD; Behr B; Conti M
    Hum Reprod; 1998 May; 13(5):1248-54. PubMed ID: 9647555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3.
    Beierwaltes WH
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1376-81. PubMed ID: 16449359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcellular localization and biological function of specific cyclic nucleotide phosphodiesterases.
    Manganiello VC
    J Mol Cell Cardiol; 1987 Oct; 19(10):1037-40. PubMed ID: 2830403
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5.
    Dunkern TR; Hatzelmann A
    Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells.
    Jiang X; Li J; Paskind M; Epstein PM
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11236-41. PubMed ID: 8855339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: advances in the development of specific phosphodiesterase inhibitors.
    Castro A; Jerez MJ; Gil C; Martinez A
    Med Res Rev; 2005 Mar; 25(2):229-44. PubMed ID: 15514991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple assay of cyclic nucleotide phosphodiesterase using 32phosphorus labeled nucleotide; application to kidney subcellular fractions.
    Eisman JA; Martin TJ
    Anal Biochem; 1976 May; 72():380-8. PubMed ID: 182037
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclic nucleotide phosphodiesterases of human and rat gastric mucosa.
    Klotz U; Antonin KH; Bieck P
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):187-90. PubMed ID: 189231
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
    Manns JM; Brenna KJ; Colman RW; Sheth SB
    Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic nucleotide phosphodiesterase from Spinacea oleracea L: subcellular distribution and properties [proceedings].
    Edwards M; Brown EG; Newton RP; Smith CJ
    Biochem Soc Trans; 1977; 5(4):975-7. PubMed ID: 199507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.